Login / Signup

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.

Simon R HellerTadej BattelinoTimothy S BaileyThomas R PieberUlrike HoevelmannLeona Plum-MörschelAnita E MelgaardRonnie AronsonLinda A DiMeglioThue JohansenThomas Danne
Published in: Diabetes, obesity & metabolism (2023)
Dasiglucagon was well tolerated and effective as a rapid rescue agent for insulin-induced SH in people with T1D.
Keyphrases
  • type diabetes
  • drug induced
  • high glucose
  • diabetic rats
  • early onset
  • glycemic control
  • metabolic syndrome
  • insulin resistance
  • adipose tissue
  • loop mediated isothermal amplification